Werewolf Therapeutics, Inc. (HOWL)

Werewolf Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	21.99	57.05	111	134.34	129.32	157.53
Cash & Short-Term Investments	21.99	57.05	111	134.34	129.32	157.53
Cash Growth	-71.67%	-48.60%	-17.38%	3.89%	-17.91%	70.17%
Accounts Receivable	-	-	-	0.4	4.1	-
Other Receivables	-	-	-	0.95	2.83	-
Receivables	-	-	-	1.35	6.93	-
Prepaid Expenses	0.91	1.54	2.07	2.47	3.96	3.44
Restricted Cash	-	-	-	0.21	-	0.1
Total Current Assets	22.89	58.59	113.07	138.37	140.2	161.07
Property, Plant & Equipment	1.26	9.9	12.32	14.85	17.45	16.33
Other Long-Term Assets	-	0.91	1.54	21.62	2.59	1.86
Total Assets	24.16	69.4	126.93	174.83	160.25	179.25

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	1.94	0.75	3.04	1.34	1.22	2.04
Accrued Expenses	5.81	5.26	10.23	8.41	13.41	8.6
Current Portion of Long-Term Debt	-	28.24	-	6.67	-	-
Current Portion of Leases	-	1.75	1.56	1.61	2.08	1.07
Current Unearned Revenue	-	-	-	0.91	6.53	-
Other Current Liabilities	0.12	0.15	0.36	0.45	0.74	0.16
Total Current Liabilities	7.86	36.15	15.18	19.38	23.99	11.87
Long-Term Debt	-	-	26.1	32.66	-	-
Long-Term Leases	-	7.68	9.44	10.99	12.6	14.59
Long-Term Unearned Revenue	-	-	-	0.43	1.13	-
Other Long-Term Liabilities	-	0.76	2.83	-	0.19	-
Total Liabilities	7.86	44.59	53.54	63.46	37.91	26.46

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.01	0.01	0.01	0	0	0
Additional Paid-In Capital	501.56	500.21	487.97	455.44	429.04	405.68
Retained Earnings	-485.27	-475.41	-414.59	-344.07	-306.71	-252.9
Total Common Equity	16.29	24.81	73.39	111.37	122.34	152.79
Shareholders' Equity	16.29	24.81	73.39	111.37	122.34	152.79
Total Liabilities & Equity	24.16	69.4	126.93	174.83	160.25	179.25

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	-	37.67	37.09	51.92	14.68	15.66
Net Cash (Debt)	21.99	19.38	73.91	82.42	114.63	141.87
Net Cash Growth	-45.64%	-73.78%	-10.33%	-28.10%	-19.20%	57.58%
Net Cash Per Share	0.46	0.41	1.69	2.31	3.97	7.69
Filing Date Shares Outstanding	48.6	48.6	44.83	42.74	35.28	27.65
Total Common Shares Outstanding	48.6	48.6	44.83	39.11	31.52	27.61
Working Capital	15.03	22.44	97.89	118.99	116.21	149.19
Book Value Per Share	0.34	0.51	1.64	2.85	3.88	5.53
Tangible Book Value	16.29	24.81	73.39	111.37	122.34	152.79
Tangible Book Value Per Share	0.34	0.51	1.64	2.85	3.88	5.53
Machinery	-	3.34	3.34	3.16	2.32	1.07
Construction In Progress	-	-	-	-	0.11	1.96
Leasehold Improvements	-	7.97	7.97	7.97	7.97	0.27

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: May 7, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 11, 2026

Data Sources Report a data error